References
- EVLoftus. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology 2004;126:1504–17.
- NJTalley, MTAbreu, JPAchkar, CNBernstein, MCDubinsky, SBHanauer. An evidence-based systematic review on medical therapies for inflammatory bowel disease. Am J Gastroenterol 2011;106:S2–S25.
- DKPodolsky. Inflammatory bowel disease. N Engl J Med 2002;347:417–29.
- NAMolodecky, ISSoon, DMRabi, WAGali, MFerris, GChernoff. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 2012;142:46–54.
- JLSwell, HFYee, JMInadomi. Hospitalizations are increasing among minority patients with Crohn’s disease and ulcerative colitis. Inflamm Bowel Dis 2010;16:204–7.
- BKMangat, CEvaschesen, TLee, EMYoshida, BSalh. Ethnic variation in the annual rates of adult inflammatory bowel disease in hospitalized patients in Vancouver, British Columbia. Can J Gastroenterol 2011;25:73–7.
- OMDamas, DAJahann, RReznik, JLMcCauley, LTamariz, ARDeshpande. Phenotypic manifestations of inflammatory bowel disease differ between hispanics and non-hispanic whites: results of a large cohort study. Am J Gastroenterol 2013;108:231–9.
- DBasu, ILopez, AKulkarni, JHSellin. Impact of race and ethnicity on inflammatory bowel disease. Am J Gastroenterol 2005;100:2254–61.
- KTThia, EVLoftus, WJSandborn, SKYan. An update on the epidemiology of inflammatory bowel disease in Asia. Am J Gastroenterol 2008;103:3167–82.
- KKLin, JLSewell. The Effects of race and socioeconomic status on immunomodulator and anti-tumor necrosis factor use among ambulatory patients with inflammatory bowel disease in the United States. Am J Gastroenterol 2013;108:1824–30.
- AJYarur, MTAbreu, MSSalem, ARDeshpande, DASussman. The Impact of Hispanic Ethnicity and Race on Post-Surgical Complications in Patients with Inflammatory Bowel Disease. Dig Dis Sci 2014;59:126–34.
- Fact Sheet on Haitian Immigrants in the United States. Center for Immigration Studies; 2010. Available from https://cis.org/HaitianImmigrantFactSheet. Accessed 2April 2014.
- Cape Verdean Immigration. North American Immigration, 2011. Available from http://northamericanimmigration.org/55-cape-verdean-immigration.html. Accessed 2April 2014.
- SSMahid, KSMinor, RESoto, CAHornung, SGalandiuk. Smoking and inflammatory bowel disease: a meta-analysis. Mayo Clin Proc 2006;81:1462–71.
- AKarban, REliakim. Effect of smoking on inflammatory bowel disease: Is it disease or organ specific? World J Gastroenterol 2007;13:2150–2.
- JATuvlin, SSRaza, SBracamonte, CJulian, SBHanauer, DLNicolae, et al. Smoking and inflammatory bowel disease: trends in familial and sporadic cohorts. Inflamm Bowel Dis 2007;13:573–9.
- JFJackson, AKornbluth. Do Black and Hispanic Americans in inflammatory bowel disease (IBD) receive inferior care compared with White Americans? Uneasy questions and speculations. Am J Gastroenterol 2007;102:1343–9.
- GCNguyen, TALaVeist, MLHarris, MHWang, LWDatta, SRBrant. Racial disparities in utilization of specialist care and medications in inflammatory bowel disease. Am J Gastroenterol 2010;105:2202–8.
- JHou, HEl-Serag, JSellin, SThirumurthi. Inflammatory bowel disease characteristics and treatment in Hispanic and Caucasians. Dig Dis Sci 2011;56:1476–81.
- MDLong, CFMartin, CAPipkin, HHHerfarth, RSSandler, MDKappelman. Risk of melanoma and nonmelanoma skin cancer among patients with inflammatory bowel disease. Gastroenterology 2012;143:390–9.
- HSingh, ZNugent, AADemers, CNBerstein. Increased Risk of Nonmelanoma Skin Cancers Among Individuals With Inflammatory Bowel Disease. Gastroenterology 2011;141:1612–20.
- SKWasan, AHCalderwood, MDLong, MDKappelman, RSSandler, FAFarraye. Immunization rates and vaccine beliefs among patients with inflammatory bowel disease: an opportunity for improvement. Inflamm Bowel Dis 2014;20:246–50.
- MMoscandrew, UMahadevan, SKane. General Health Maintenance in IBD. Inflamm Bowel Dis 2009;15:1399–408.
- JASinclair, SKWasan, FAFarraye. Health maintenance in the inflammatory bowel disease patient. Gastroenterol Clin North Am 2012;41:325–37.
- GYMelmed, AFIppoliti, KAPapadakis, TTTran, JLBirt, SKLee. Patients with inflammatory bowel disease are at risk for vaccine-preventable illnesses. Am J Gastroenterol 2006;101:1834–40.